Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin.

ABSTRACT: Despite recent advances in treatment, cancer continues to be one of the most lethal human maladies. One of the challenges of cancer treatment is the diversity among similar tumors that exhibit different clinical outcomes. Most of this variability comes from wide-spread molecular alterations that can be summarized by omic integration. Here, we have identified eight novel tumor groups (C1-8) via omic integration, characterized by unique cancer signatures and clinical characteristics. C3 had the best clinical outcomes, while C2 and C5 had poorest. C1, C7, and C8 were upregulated for cellular and mitochondrial translation, and relatively low proliferation. C6 and C4 were also downregulated for cellular and mitochondrial translation, and had high proliferation rates. C4 was represented by copy

SUBMITTER: Gonzalez-Reymundez A 

PROVIDER: S-EPMC7239905 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature